MannKind Corp. (MNKD)
5.72
+0.23
(+4.19%)
USD |
NASDAQ |
Jan 21, 16:00
5.71
-0.01
(-0.17%)
After-Hours: 18:38
MannKind Free Cash Flow: 42.74M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amicus Therapeutics, Inc. | 9.691M |
| Keros Therapeutics, Inc. | 87.08M |
| Moderna, Inc. | -2.663B |
| Vertex Pharmaceuticals, Inc. | 3.337B |
| TG Therapeutics, Inc. | -70.24M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 23.49M |
| Cash from Investing (Quarterly) | -25.06M |
| Cash from Financing (Quarterly) | 71.96M |
| Free Cash Flow Per Share (Quarterly) | 0.0718 |
| Free Cash Flow to Equity (Quarterly) | -50.52M |
| Free Cash Flow to Firm (Quarterly) | 29.89M |
| Free Cash Flow Yield | 2.42% |